CFM
OLMA icon

Compass Financial Management’s Olema Pharmaceuticals OLMA Stock Holding History

Compass Financial Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62K Buy
+308
New +$4.13K ﹤0.01% 1246

Other funds holding OLMA

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Compass Financial Management's OLMA Position: Q2 2026 in Review

Compass Financial Management opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 308 shares worth $3.62K. The stake represents ﹤0.01% of the portfolio and ranks #1246 among its holdings.

167 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Compass Financial Management held 308 shares of Olema Pharmaceuticals worth $3.62K as of Q2 2026.
  • Olema Pharmaceuticals was a new Compass Financial Management position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Compass Financial Management's portfolio in Q2 2026, its #1246 holding.
  • 167 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Compass Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.